StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Lipella Pharmaceuticals's ebitda for the twelve months ending Sep 30, 2025 was -$5.41M. For fiscal 2024 it was -$5.08M.

Annual ebitda

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$5.08M–
FY2023Dec 31, 2023-$4.74M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$1.27M–
Q2 FY2025Jun 30, 2025-$1.36M–
Q1 FY2025Mar 31, 2025-$1.33M–
Q4 FY2024Dec 31, 2024-$1.45M–
Q3 FY2024Sep 30, 2024-$1.46M–
Q2 FY2024Jun 30, 2024-$951.47K–
Q1 FY2024Mar 31, 2024-$1.22M–
Q4 FY2023Dec 31, 2023-$728.87K–

More Lipella Pharmaceuticals figures

See a number that looks wrong?